Joslin Diabetes Center
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Joslin Diabetes Center sits in the top decile of US sponsors by registered trial count (#295 of 15,742 sponsors by registered trial count).
Joslin Diabetes Center: 73 sponsored US clinical trials, 7 recruiting.
Joslin Diabetes Center sponsors 73 registered US clinical trials on ClinicalTrials.gov, 7 of them currently recruiting, and 56 completed. 6 of these trials are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypoglycemia, with 6 trials.
Top-decile sponsor footprint
Joslin Diabetes Center ranks in the top decile of sponsors by registered trial count (#295 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
56 of 59 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (94.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
73 total, page 1 of 2
Nutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Type 2 Diabetes Patients Treated With Incretin Mimetics
NCT07271043
Postnatal Exercise to Activate Baby's Brown Fat
NCT07467694
Exercise, Brain Activity, and Weight Maintenance
NCT06511310
External Carotid Blood Flow in Individuals With Post-Bariatric Hypoglycemia
NCT07082478
Diabetes Body Project 2
NCT07468188
The PRECISION II Study: Evaluating the Accuracy of the LabPatch Glucose Sensing System
NCT05754281
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
NCT05826678
Glucagon Dose-Response in Patients With Post-Bariatric Hypoglycemia
NCT06986603
The REST Study for CGM Use in Older Adults With Insulin-treated Diabetes
NCT05337826
Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes
NCT04595474
Mechanisms of Hypoglycemia in Patients Without Diabetes
NCT04428723
Hypoglycemia and the Gut Microbiome
NCT03385707
Impact of Metabolic Health on Sperm Epigenetic Marks in Humans
NCT03860558
Evaluating the Health Outcomes of the Joslin Why WAIT Program
NCT01937845
Deprescribing of Diabetes Regimens in Long Term Care Residents With Alzheimer's
NCT05535478
The Effect of Physical Activity in Individuals With Post-bariatric Hypoglycemia
NCT05560789
Healthy And Positive Pathways for Young People With Type 1 Diabetes (HAPPY T1D)
NCT05413239
Continuous Glucose Monitoring (CGM) in Long Term Care (LTC) Facilities
NCT05711108
Oral Hypoglycemic Therapy for Monogenic Variant Carriers of the Joslin Medalist Study
NCT04409795
Effects of a Single Bout of Exercise on Transcriptomics and Metabolomics in Adipose Tissue
NCT04865965
Cognition in Patients With Hypoglycemia, Without Diabetes
NCT04430582
Continuous Glucose Monitoring to Reduce Hypoglycemia and Improve Safety After Gastric Surgery
NCT03353415
Patient and Parent Preferences for an On-Body Automated Insulin Delivery System
NCT03534544
Mechanisms of Exercise Resistance in Metabolic Disease
NCT03945435
Increasing Heart Healthy Behaviors in Youth With Type 1 Diabetes
NCT03531021
PERL Continuous Glucose Monitoring (CGM) Study
NCT03334318
Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia
NCT03255629
Effects of Cinnamon Supplementation on Glucose Metabolism in Patients With Pre-diabetes
NCT03219411
Exercise Regulation of Human Adipose Tissue
NCT03133156
Technological Advances in Glucose Management in Older Adults
NCT03078491
PRECISION Study: Evaluating the Accuracy of the LabPatch Continuous Glucose Monitor
NCT03262415
Investigation of Exercise Training-Induced Myokines and Adipolkines in Humans
NCT03037216
Insulin Dosing Practices in Persons With Diabetes on Multiple Daily Injections
NCT02914730
Effect of Dairy Consumption on Glycemic Control, Body Weight and Cardiovascular Risk in Patients With Type 2 Diabetes
NCT02895867
Effect of Dairy Consumption on Glycemic Control, Body Weight and Cardiovascular Risk Factors
NCT02896140
The Effects of Exercise of Secreted Factors From Muscle and Adipose Tissue
NCT02565823
Use of Mobile-based Technologies to Improve Diabetes Self-management and Postprandial Glucose Control
NCT02556398
Impact of a Virtual Diabetes Self-Care and Education Program on Diabetes-related Outcomes in Latinos With T2 Diabetes
NCT02488785
The Effect of 3 Different Models of MNT on DM Control in Overweight Patients With T2DM
NCT02520050
OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits
NCT01875783
Metabolic Effects of Betaine Supplementation
NCT01950039
Effect of Gain on Closed-Loop Insulin
NCT02065895
Optimizing Self-Management Adherence and Glycemic Control in Older Teens With Type 1 Diabetes: The Teenwork Study
NCT01892280
Gluten Immunity and Islet Autoimmunity in Type-1 Diabetes
NCT01932476
Evaluation of Fats on Postprandial Glucose Control
NCT01869790
Adopting a Physically Active Lifestyle Through Organized Walk Events Among Joslin Clinic Patients
NCT01888133
Evaluation of a Prototype Diabetes Management System Applied to Insulin Initiation and Titration
NCT01698528
Barriers to Adherence to Recommended Follow-up in Women With a History of Gestational Diabetes
NCT01681147
Evaluating the Effect of Diabetes Control Through Intensive Lifestyle Modifications on Diabetic Peripheral Neuropathy
NCT01565317
Can Glucose Monitoring Improve (CGMi Study)
NCT01472159
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 7 |
| Phase 3 | 1 |
| Phase 4 | 5 |
Therapeutic Areas
What is open in the Joslin Diabetes Center pipeline
7 recruiting of 73 indexed (10% open); 56 completed (77%).
Phase mix: 6 late (III/IV) vs 8 early (I/II) (balanced across stages).
Top condition: Hypoglycemia (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Joslin Diabetes Center: open-pipeline peers nationwide
Peers matched on 73 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
Joslin Diabetes Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 73 trials (± recruiting share)
- Denver Health and Hospital Authority · 73 trials · 5% recruiting
- Hugo W. Moser Research Institute at Kennedy Krieger · 73 trials · 23% recruiting
- Massachusetts Eye and Ear Infirmary · 73 trials · 27% recruiting
- Tulane University · 73 trials · 30% recruiting
Sponsors near 10% open enrollment (± trial volume)
- Children's Oncology Group · 10% recruiting · 342 trials
- Apellis Pharmaceuticals · 10% recruiting · 21 trials
- Hologic · 10% recruiting · 21 trials
- Southern Illinois University · 10% recruiting · 21 trials
Related
What to do with this Joslin Diabetes Center page
73 registered trials is a research-attention snapshot, not an endorsement of Joslin Diabetes Center or any single study.
- 7 of Joslin Diabetes Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypoglycemia is the condition Joslin Diabetes Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypoglycemia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Joslin Diabetes Center pipeline card: 73 registered trials from official public datasets.Report a data error.